Nandi Chinmay, Mitra Kaushik, Bhaumik Dipankar
District Nodal Officer, NUHM, North 24 Parganas, Kolkata, West Bengal, India.
Department of Community Medicine, Burdwan Medical College, Burdwan, West Bengal, India.
J Family Med Prim Care. 2022 Mar;11(3):1134-1139. doi: 10.4103/jfmpc.jfmpc_1105_21. Epub 2022 Mar 10.
The adoption of directly observed treatment short course (DOTS) in Revised National Tuberculosis Control Programme has given impressive results with higher treatment success. But interruption of treatment has been one of the major obstacles to treatment of tuberculosis.
The aim of the study was to evaluate the determinants of treatment interruption and outcome. It also evaluated the impact of treatment interruption on treatment outcomes.
The study was carried out in the area covered under Bhatar tuberculosis unit (TU) of Burdwan district of West Bengal. The study was a descriptive cross-sectional study.
Smear-positive pulmonary tuberculosis patients were taken as study subjects in both the components of study. Complete enumeration technique, rather than sampling, was followed in this study. Data were collected in a predesigned and pretested schedule.
Data were analyzed by percentages and proportion. Chi-square test was used to find the association between variables.
Gender, religion, and substance abuse were found to be statistically significant factors with interruption. It was also observed that treatment outcome was not statistically significant with age, gender, religion, and category of treatment. In the study, 84.6% of the study subjects with interruption less than 1 week had favorable outcome. But in study subjects with longer duration of interruption (≥2 weeks), only 12.5% had favorable outcome. Not only interruption, duration of interruption was found to be adversely affecting the treatment outcome.
Interruption had an impact on the treatment outcome in the present study. Unfavorable outcomes were significantly more frequent among patients with interruption as compared to those without any interruption.
修订后的国家结核病控制规划采用直接观察短程治疗(DOTS)取得了令人瞩目的成果,治疗成功率更高。但治疗中断一直是结核病治疗的主要障碍之一。
本研究的目的是评估治疗中断的决定因素及结果。还评估了治疗中断对治疗结果的影响。
本研究在西孟加拉邦布德万区巴塔尔结核病防治单位(TU)覆盖的地区开展。该研究为描述性横断面研究。
在研究的两个部分中,痰涂片阳性的肺结核患者均作为研究对象。本研究采用的是完全枚举技术,而非抽样。数据按照预先设计和预测试的时间表收集。
数据通过百分比和比例进行分析。采用卡方检验来确定变量之间的关联。
发现性别、宗教和药物滥用是与治疗中断有统计学显著意义的因素。还观察到治疗结果与年龄、性别、宗教和治疗类别无统计学显著关联。在该研究中,中断治疗少于1周的研究对象中,84.6%的患者治疗结果良好。但在中断治疗时间较长(≥2周)的研究对象中,只有12.5%的患者治疗结果良好。不仅治疗中断,中断时间也被发现对治疗结果有不利影响。
在本研究中,治疗中断对治疗结果有影响。与未中断治疗的患者相比,中断治疗的患者出现不良结果的频率明显更高。